Category Archives: BioInformatics

Researchers from the European Bioinformatics Institute (EMBL-EBI), University of Cambridge, the Wellcome Trust Sanger Institute and the Cancer Research UK-Cambridge Institute (CRUK-CI) have shed light on a long-standing debate about why the immune system weakens with age. Their findings, published in Science, show that immune cells in older tissues lack coordination and exhibit much more variability in gene expression compared with their younger counterparts. Settling the debate We've all witnessed the progressive decline of function that comes with aging, but what exactly causes this decline - and why does it happen at different rates for different parts of the body? To find answers, scientists need to unpick all of the mechanisms of aging at the molecular level, for every tissue. Today's study focused on immune tissue: specifically, CD4+ T cells. The immune system is like a symphony orchestra, with many different types and subtypes of cells working together to fight infections. But as the immune system ages, its response to infection weakens for reasons that are not yet clear. One long-standing debate amongst scientists concerns two central hypotheses: either the functional degradation is caused by a loss of cellular performance, or it is down to a loss of coordination among … Continue reading →

Bioinformatics Infrastructure Facility (BIF), Guwahati Jobs Notification, Bioinformatics Infrastructure Facility (BIF), Guwahati will be conducting Walk in- Interview and invites eligible candidates to appear for the Walk in- Interview for the post of Traineeship and Studentship in Bioinformatics Centre, Gauhati. Posts are purely on Temporary Basis for specific period of 06 months. The eligible candidates can apply to the post through the prescribed format on or before 31 March 2017. Traineeship candidates should possess Masters Degree (M.Sc.) in appropriate discipline. Studentship candidates should possess Post- Graduate Degree in the respective discipline of Bioinformatics or Biotechnology or any branch of Life Science. Eligible candidates may appear for the Walk in- Interview and submit the application for the said post in the prescribed format along with other necessary documents as required at the office of the Professor & Coordinator, Bioinformatics Infrastructure Facility Guwahati (BIFGU), Zoology Dept., Gauhati University, Guwahati - 14 on or before 31 March 2017. Candidates have to bring the original documents for verification at the time of Interview. Official Notification Vacancy Summary Important Date: Last Date of Application: 31 March 2017. Age Limit Gen/ OBC/ SC/ ST/ PWD: As per norms. Selection Procedure for Trainee and Studentship Jobs The … Continue reading →

MCLEAN, Va., March 27, 2017 /PRNewswire/ --Perthera's Chief Bioinformatics Officer and research faculty member at Georgetown Lombardi Cancer Center, Subha Madhavan, Ph.D., will be speaking at the American Medical Informatics Association (AMIA) 2017 Joint Summits Panels. On Monday, March 27, 2017, she will be speaking on the topic of "Making Precision Oncology Data More Usable for Research and Care" (from 10:30 a.m. 12:00 p.m. PST) and on Tuesday, March 28, 2017, she will be a participant in the "Making Precision Oncology Data More Usable for Research and Care" panel (from 1:30 p.m. 3:00 p.m. PST). During the "Information Technology Powering Cancer Research for Discovery and Novel Hypothesis Generation" panel, Dr. Madhavan will be joined by Dr. Joel Saltz from Stony Brook University, Dr. Guoqian Jiang, M.D., Ph.D. from the Mayo Clinic, and Dr. Hua from the University of Texas Health Science Center at Houston. AMIA states the panel will "highlight four cancer technology development projects that describe various platforms that demonstrate the use of computational methods, tools, and framework to drive discovery in the era of rapidly accumulating big data." For her second panel, "Making Precision Oncology Data More Usable for Research and Care," Dr. Madhavan will be joined by … Continue reading →

Grand View Research, Inc. Market Research And Consulting. According to new report by Grand View Research, The Global bioinformatics market size was valued at USD 3.51 billion in 2013. Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market. The global bioinformatics market is expected to reach USD 13.47 billion by 2020 growing at an estimated CAGR of 21.2% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market growth over the next five years. Further development of bioinformatics tools, platforms and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry. Full research report onbioinformatics market analysis: http://www.grandviewresearch.com/industry-analysis/bioinformatics-industry Growth in the number of research and development studies in various -omics related segments and need for integration of the large amounts of biological data generated from these studies is also expected to encourage … Continue reading →

IT Business Net Global Bioinformatics Market Is Expected To Reach USD 38614.0 Mn By 2024 - Credence Research IT Business Net Global Bioinformatics Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2023, the bioinformatics market was valued at USD 8,580.0 Mn in 2015, and is expected to reach USD 38,614.0 Mn by 2024, expanding at a CAGR of ... and more » See the rest here: Global Bioinformatics Market Is Expected To Reach USD 38614.0 Mn By 2024 - Credence Research - IT Business Net … Continue reading →

MedCity News Omicia pivots to the clinic and rebrands as Fabric Genomics MedCity News Omicia was beginning to realize its vision to fully integrate into the clinical world as an end-to-end bioinformatics provider. The final step was a company rebrand. It's really about our insight and analytics being embedded deeply within healthcare ... Omicia Rebrands as Fabric Genomics, Inks Strategic Partnership With SentieonGenomeWeb Fabric Genomics and Sentieon Sign Strategic Partnership to Bring Advanced Genomic Analysis Capabilities to the ...Yahoo Finance Omicia Rebrands as Fabric Genomics; Launches New End-to-End ...Business Wire (press release) all 4 news articles » Read the rest here: Omicia pivots to the clinic and rebrands as Fabric Genomics - MedCity News … Continue reading →

Bioinformatics can be described as a field which develops various protocols and software tools to make sense of or glean insights from biological data. Bioinformatics tools utilize the relevant aspects of fields like computer science, engineering,., to break down and make sense of biological information. Various offshoots of bioinformatics research, like computational biology, have gained a very positive following and are being increasingly used in various branches of biology. The future of bioinformatics programs seems to be heading toward the integration and maintenance of bioinformatics databases with the development and discovery of next generation drugs. Scope & Regional Forecast of the Bioinformatics Market The Bioinformatics Market considers the prime growth drivers to be a few factors like: extensive usage of bioinformatics analysis in understanding genomic patterns contained within DNA; usage of bioinformatics technology to analyze and breakdown the structure of various proteins; bioinformatics companies being able to gradually integrate their services into the healthcare infrastructure; improvements being made to bioinformatics research as a result of innovations in data analytics as well as cloud computing. The Bioinformatics Market revenue is expected to cross the $16 billion mark in 2022 and will also be accompanied by a CAGR of 20.83%. The sectors … Continue reading →

Seven Bridges, the biomedical data analysis company, today announced its Scientific Advisory Board, which formalizes relationships with leading global experts in genomic medicine, bioinformatics and cancer research. Members of the Seven Bridges Scientific Advisory Board will advise on the companys product designs and strategies for cloud-based biomedical data analysis, as well as share their knowledge about key challenges and opportunities in the field of genomic research. The inaugural members of the Seven Bridges Scientific Advisory Board include: As we continue to build on Seven Bridges vision to connect the worlds biomedical data for better research and health, input from leaders in the fields of genetics, bioinformatics and cancer research will prove invaluable to our efforts, said Brandi Davis-Dusenbery, CEO of Seven Bridges. We are honored that these respected experts have agreed to participate in our SAB and look forward to working with them to constantly advance the state of the art in data analysis for our large-scale pharmaceutical and government clients. About Seven Bridges Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. The scalable, cloud-based Seven Bridges Platform empowers rapid, collaborative analysis of millions of genomes in concert … Continue reading →

Details WhaTech Channel: Medical Market Research Published: 14 March 2017 Submitted by Shubham Dwivedi WhaTech Pro+ News from Data Bridge Market Research Viewed: 1 times Global bioinformatics market is expected to reach USD 22.78 billion by 2024 from USD 6.54 billion in 2016, at a CAGR of 16.8% in the forecast period 2017 to 2024. The global bioinformatics market is segmented based on industry, product type, service and application.. Based on industry, the bioinformatics market is segmented into molecular medicine, drug development, clinical diagnostics, agriculture, forensic, animal, academics and research, environmental and gene therapy. Based on product type, the bioinformatics market is segmented into sequencing platforms, knowledge management tools and bioinformatics software. Based on applications, the bioinformatics market is segmented into preventive medicine, molecular medicine, genomics, drug development, transcriptomics and, other biotechnological applications. Based on services, the bioinformatics market is segmented into data analysis, sequencing, data integration among others. Request for sample pages: databridgemarketresearch.com/reports/global-bioinformatics-market/ Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, … Continue reading →

About Conference Conference Series LLClike to take this opportunity to welcome all of you to 9thInternational Conference & Expo on Proteomics which is to be held during November 02-04, 2017 at Paris, France. Through our theme Exploring the hidden depths of the proteomics, the conference will analyze the recent advancements and new modes that can be enforced to the research to take Proteomics, one step further. Proteomics Congress 2017 conference will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. The conference also includes essential topics onProtein Expressionand Analysis,ProteomicsDatabase,Mass Spectrometryin Proteome Research, Proteomics from Discovery to Function,Analytical Proteomicsand Genomics, Protein Biochemistry and Proteomics, Proteomics inPersonalized Medicine, Cardiovascular Proteomics, Proteomics in Computational and Systems Biology, Proteomics forBioinformatics, Plant Proteomics and Applications, Food andNutritional Proteomics, Cancer and Clinical proteomics, Immunoproteomics,Protein Engineeringand Molecular Design,Neuroproteomics& Neurometabolomics and many more. Conference Series LLCcoordinates 1000+Global events. Every Year across USA, Europe and Asia with backing from 1000 morescientific societies& Publishes 700+Open access journalswhich encompass over 100000 eminent personalities, reputed scientists as an editorial board & organizing committee members. Conference Series LLC is … Continue reading →